PROCTER & GAMBLE HEALTH
|
The Current P/B Ratio of PROCTER & GAMBLE HEALTH is 10.65.
Share Price | ₹4,769.0 | May 30,2024 |
Market Cap | ₹7,916.5 Cr | |
Book Value | ₹743.1 Cr | Jun2023 - Standalone Results |
Price/Book | 10.65x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of PROCTER & GAMBLE HEALTH
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹7,916.5 Cr] as on May 30,2024
(/) Book Value [ ₹743.1 Cr] based on Jun2023 - Standalone Results
(=) P/B Ratio [ 10.65x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '10.65 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/B Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PB (Price/Book ) ratio chart of PROCTER & GAMBLE HEALTH
PB Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/b ratio for fiscal years ending Jun2023 to Dec2018 averaged 9.44x.
- PROCTER & GAMBLE HEALTH 's operated at median p/b ratio of 11.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/b ratio peaked in Jun2021 at 13.27x.
- PROCTER & GAMBLE HEALTH 's p/b ratio hit its five-year low in Dec2018 of 3.32x.
How does PROCTER & GAMBLE HEALTH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
PROCTER & GAMBLE HEALTH | 743.05 | 10.65 | 7,916.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 5.50 | 350,195.0 |
CIPLA LTD | 26,706.40 | 4.43 | 118,275.0 |
DR REDDYS LABORATORIES LTD | 28,254.80 | 3.47 | 98,034.1 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 5.19 | 102,998.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 8.63 | 117,130.0 |
MANKIND PHARMA LTD | 9,363.09 | 8.96 | 83,883.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.23 | 13.13 | 89,994.3 |
LUPIN LTD | 14,290.30 | 5.03 | 71,920.7 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.36 | 70,303.8 |
ABBOTT INDIA LTD | 3,698.89 | 14.93 | 55,229.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PROCTER & GAMBLE HEALTH 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.36x |
Max industry PB | 14.93x |
Median industry PB | 5.50x |
Average industry PB | 7.48x |
You may also like the below Video Courses